Webinars and Videos
Credible effect, post-published data and functionality defined antibody claims ǀ European biotech patent case law series (February 2024)
European patent attorneys Simon O'Brien and Tom Pagdin present our latest webinar update of new and important European Patent Office (EPO) biotechnology patent case law.
The webinar includes discussion of the latest European biotech patent case law developments including:
- T 2036/21: Standard for credible effect/free evaluation of evidence
- T 1989/19: Allowability of post-published data to support inventive step
- T 0835/21: Enablement of functionally defined antibody claims
System requirements
To view our webinars we recommend the following internet browsers:
- Google Chrome (most recent 2 versions).
- Mozilla Firefox (most recent 2 versions).
- Apple Safari (most recent 2 versions).
- Microsoft Edge (most recent 2 versions).
Patent-Newsletter
Neueste Ausgabe